EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy

Ying Gao, Lu Li, Fang Zhao, Yi Cheng, Mu Jin, Fu-Shan Xue iD

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s504179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Ying Gao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Ketamine, Reperfusion Injury, Autophagy, Microglia. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineReperfusion InjuryAutophagyMicrogliaProto-Oncogene Proteins c-aktBrain IschemiaNeuroprotective AgentsAnimalsRatsMaleSignal TransductionRats, Sprague-DawleyDose-Response Relationship, DrugMiceDisease Models, AnimalCells, CulturedInfarction, Middle Cerebral Artery

Stichwörter der Autor:innen

autophagycerebral ischemia/reperfusion injuryesketamineischemic strokemicroglia polarization

Substanzen

KetamineProto-Oncogene Proteins c-aktNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Hospital, Fuzhou, People's Republic of China.

ORCID-Profile: Fu-Shan Xue

Zitieren

APA

Gao, Y., Li, L., Zhao, F., Cheng, Y., Jin, M., & Xue, F. S. (2025). Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s504179

Vancouver

Gao Y, Li L, Zhao F, Cheng Y, Jin M, Xue FS. Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s504179

BibTeX
@article{Gao2025,
  author = {Gao, Ying and Li, Lu and Zhao, Fang and Cheng, Yi and Jin, Mu and Xue, Fu-Shan},
  title = {Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s504179}
}
Kostenlos starten →